In Vitro Measurement and Mathematical Modeling of Thermally-Induced Injury in Pancreatic Cancer Cells

Author:

Chamani Faraz1,Pyle Marla M.2,Shrestha Tej B.23,Sebek Jan1ORCID,Bossmann Stefan H.4ORCID,Basel Matthew T.2,Sheth Rahul A.5ORCID,Prakash Punit1ORCID

Affiliation:

1. Department of Electrical and Computer Engineering, Kansas State University, Manhattan, KS 66506, USA

2. Department of Anatomy and Physiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506, USA

3. Nanotechnology Innovation Center of Kansas State (NICKS), Kansas State University, Manhattan, KS 66506, USA

4. Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS 66160, USA

5. Department of Interventional Radiology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA

Abstract

Thermal therapies are under investigation as part of multi-modality strategies for the treatment of pancreatic cancer. In the present study, we determined the kinetics of thermal injury to pancreatic cancer cells in vitro and evaluated predictive models for thermal injury. Cell viability was measured in two murine pancreatic cancer cell lines (KPC, Pan02) and a normal fibroblast (STO) cell line following in vitro heating in the range 42.5–50 °C for 3–60 min. Based on measured viability data, the kinetic parameters of thermal injury were used to predict the extent of heat-induced damage. Of the three thermal injury models considered in this study, the Arrhenius model with time delay provided the most accurate prediction (root mean square error = 8.48%) for all cell lines. Pan02 and STO cells were the most resistant and susceptible to hyperthermia treatments, respectively. The presented data may contribute to studies investigating the use of thermal therapies as part of pancreatic cancer treatment strategies and inform the design of treatment planning strategies.

Funder

NIH

KSU Johnson Cancer Research Center

Publisher

MDPI AG

Subject

Cancer Research,Oncology

Reference61 articles.

1. Pancreatic cancer;Mizrahi;Lancet,2020

2. National Institutes of Health (NIH) (2022, November 10). Annual Report to the Nation: Cancer Deaths Continue Downward Trend; Modest Improvements in Survival for Pancreatic Cancer. 27 October 2022, Available online: https://www.nih.gov/news-events/news-releases/annual-report-nation-cancer-deaths-continue-downward-trend-modest-improvements-survival-pancreatic-cancer.

3. Pancreatic cancer;Maitra;Annu. Rev. Pathol.,2008

4. Adamska, A., Domenichini, A., and Falasca, M. (2017). Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies. Int. J. Mol. Sci., 18.

5. Pancreatic cancer: Why is it so hard to treat?;Oberstein;Ther. Adv. Gastroenterol.,2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3